Sardanelli, Francesco http://orcid.org/0000-0001-6545-9427
Trimboli, Rubina M.
Houssami, Nehmat
Gilbert, Fiona J.
Helbich, Thomas H.
Álvarez Benito, Marina
Balleyguier, Corinne
Bazzocchi, Massimo
Bult, Peter
Calabrese, Massimo
Camps Herrero, Julia
Cartia, Francesco
Cassano, Enrico
Clauser, Paola
Cozzi, Andrea
de Andrade, Danúbia A.
de Lima Docema, Marcos F.
Depretto, Catherine
Dominelli, Valeria
Forrai, Gábor
Girometti, Rossano
Harms, Steven E.
Hilborne, Sarah
Ienzi, Raffaele
Lobbes, Marc B. I.
Losio, Claudio
Mann, Ritse M.
Montemezzi, Stefania
Obdeijn, Inge-Marie
Ozcan, Umit A.
Pediconi, Federica
Pinker, Katja
Preibsch, Heike
Raya Povedano, José L.
Sacchetto, Daniela
Scaperrotta, Gianfranco P.
Schiaffino, Simone
Schlooz, Margrethe
Szabó, Botond K.
Taylor, Donna B.
Ulus, Özden S.
Van Goethem, Mireille
Veltman, Jeroen
Weigel, Stefanie
Wenkel, Evelyn
Zuiani, Chiara
Di Leo, Giovanni
Funding for this research was provided by:
Bayer AG
Università degli Studi di Milano
Article History
Received: 5 June 2021
Revised: 20 July 2021
Accepted: 2 August 2021
First Online: 13 October 2021
Change Date: 22 February 2022
Change Type: Update
Change Details: In this article the following funding information was added: Open access funding provided by Università degli Studi di Milano within the CRUI-CARE Agreement.
Declarations
:
: The scientific guarantor of this publication is Prof. Francesco Sardanelli, MD.
: Outside the present work, the authors declare the following relations with companies and institutions:Francesco Sardanelli received research grants from – and is a member of the speakers’ bureau of – General Electric Healthcare, Bayer, and Bracco; he is also a member of the Bracco Advisory Group.Nehmat Houssami receives research funding via a National Breast Cancer Foundation (NBCF Australia) Breast Cancer Research Leadership Fellowship.Fiona J. Gilbert received research grants from General Electric Healthcare, GSK and Hologic, and had research collaborations with Volpara and Bayer.Marc B.I. Lobbes received a research grant and is a member of the speakers’ bureau of General Electric Healthcare.Katja Pinker declares funding by the NIH/NCI Cancer Centre Support Grant P30 CA008748, Digital Hybrid Breast PET/MRI for Enhanced Diagnosis of Breast Cancer (HYPMED), H2020—Research and Innovation Framework Programme PHC-11-2015 # 667211-2, A Body Scan for Cancer Detection using Quantum Technology (CANCERSCAN), H2020-FETOPEN-2018-2019-2020-01 # 828978, Multiparametric 18F-Fluoroestradiol PET/MRI coupled with Radiomics Analysis and Machine Learning for Prediction and Assessment of Response to Neoadjuvant Endocrine Therapy in Patients with Hormone Receptor+/HER2− Invasive Breast Cancer 02.09.2019/31.08.2020 # Nr: 18207, Jubiläumsfonds of the Austrian National Bank.Simone Schiaffino received travel support from Bracco Imaging and is a member of the speakers’ bureau for General Electric Healthcare.All other authors declare that they have no conflict of interest related to the present work and that they have nothing to disclose.
: The third author (Nehmat Houssami, The University of Sydney) and the last author (Giovanni Di Leo, IRCCS Policlinico San Donato) have significant statistical expertise.
: Written informed consent was obtained from all patients in this study, unless waived by local Ethics Committees.
: This study was approved by the Ethics Committee of the coordinating centre on January 29, 2013 (protocol number 2784) and thereafter by local Ethics Committees of participating centres.
: UnorderedList removed